leisure time -WSS

leisure time

author：entertainment 2025-10-01 00:00:12 - browse：8181

Kevin Sayer, CEO of Dexcom Dexcom

For years, diabetes tech company Dexcom has been striving to get its continuous glucose monitors into the hands of type 2 diabetes patients. Last week at the American Diabetes Association’s conference, the company unveiled plans for software built entirely for these patients, including ones who don’t take insulin.

“We’ve been so focused on things that match the needs of somebody who manages diabetes every minute of every day, and insulin delivery,” Kevin Sayer, CEO of Dexcom, told STAT. “This new product is going to be designed to address the needs of somebody with diabetes who’s not doing that, who has type 2 diabetes and is on other drugs.”

Continuous glucose monitoring is already well-established among people with type 1 diabetes, who rely on constant insulin therapy. The technology, which helps patients noninvasively monitor their blood sugar levels and control their insulin pump in real time, has grown rapidly in use over the years, culminating in a $5 billion market.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： The pink breast cancer awareness ribbon needs a redesign

knowledge

WSS

Microsoft's Peter Lee says ChatGPT shouldn't be used for initial diagnosis

With measles on the rise, a personal story of a devastating disease

It's time to retire 'poor historian' from clinicians' vocabularies

Why Sanofi got shellacked over its spinoff

Big Tobacco's 'harm reduction': Is it for real, or a sham?

Readout LOUD podcast: Live from STAT Breakthrough Summit West

hotspot

leisure time

Wikipedia

Medical records are filled with copy

Testing for cancer recurrence creates a new limbo for patients

United colonoscopy coverage change 'may cost lives,' doctors say

Military medical care influenced by rank and race, new study finds

Affirmative action in medical school literally saved lives

HIV vaccine remains elusive. Immunologists keep trying new ideas

Malaria cases in Florida and Texas: Here’s what you need to know

Cytokinetics CEO stresses company can launch heart drug on its own

The high cost of giving birth even with insurance

STAT Wunderkinds: Ruey Hu's digital tools for parsing research

focus

Readout LOUD podcast: Live from STAT Breakthrough Summit West

First Opinion Podcast: How to protect health care in times of war

Solving academic medical centers' existential crisis

Readout Newsletter: Nvidia, Biogen, Ionis, AstraZeneca, ChatGPT

With measles on the rise, a personal story of a devastating disease

The FDA weighs the risks of candy

Wikipedia

leisure time

knowledge

knowledge